Sector revisions Legend Biotech Corporation

Equities

Real-time Estimate Cboe BZX Other stock markets 20:31:23 17/07/2025 BST			5-day change	1st Jan Change
42.28 ^USD	+6.36%		+6.45%	+29.90%

07-09	US lawmakers renew concerns about GenScript's ties to China	RE
07-07	RBC Lowers Price Target on Legend Biotech to $75 From $78, Keeps Outperform Rating	MT

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	4m. EPS revision	4m. Revenue rev.	1y. EPS revision	1y. Revenue rev.	Visibility (Composite)	Nbr of analysts
	LEGEND BIOTECH CORPORATION							19
	ARGENX SE							15
	WUXI APPTEC CO., LTD.							18
	BIONTECH SE							21
	SUMMIT THERAPEUTICS INC.							9
	INSMED INCORPORATED							18
	AKESO, INC.							20
	WUXI BIOLOGICS (CAYMAN) INC.							26
	GENMAB A/S							16
	EXELIXIS, INC.							19
	SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.							16
	VERONA PHARMA PLC							9
	MADRIGAL PHARMACEUTICALS, INC.							14
	SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.							2
	BIOCON LIMITED							20
	NUVALENT, INC.							10
	PHARMAESSENTIA CORPORATION							4
	REMEGEN CO., LTD.							14
	VAXCYTE, INC.							8
	Average							15
	Weighted average by Cap.							16